These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11571894)

  • 81. Blood safety.
    Talib VH; Verma SK; Pandey J; Khurana SK
    Indian J Pathol Microbiol; 1993 Apr; 36(2):170-5. PubMed ID: 8276484
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Colorado blood bank prevails in transfusion case.
    AIDS Policy Law; 1999 May; 14(10):10. PubMed ID: 11367140
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Alternative strategies in assuring blood safety: An overview.
    Epstein JS
    Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Legal considerations for allogeneic blood transfusion.
    Goldman EB
    Am J Surg; 1995 Dec; 170(6A Suppl):27S-31S. PubMed ID: 8546243
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New Federal guidelines for hepatitis C virus lookback.
    Witthaus D
    MLO Med Lab Obs; 1998 Sep; 30(9):22-6. PubMed ID: 10186315
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 88. Hepatitis C virus lookback: emerging science and public policy.
    Epstein J
    Transfusion; 2000 Jan; 40(1):3-5. PubMed ID: 10644804
    [No Abstract]   [Full Text] [Related]  

  • 89. Do safety issues of plasma products constrain self-sufficiency?
    Savidge GF
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S67-70. PubMed ID: 7795142
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pathogen inactivation: the definitive safeguard for the blood supply.
    Bryant BJ; Klein HG
    Arch Pathol Lab Med; 2007 May; 131(5):719-33. PubMed ID: 17488157
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Transfusion medicine for the pediatrician.
    Quirolo KC
    Pediatr Clin North Am; 2002 Dec; 49(6):1211-38. PubMed ID: 12580363
    [TBL] [Abstract][Full Text] [Related]  

  • 92. International views on universal leucodepletion: the perspective in NBS, Ireland.
    Murphy W
    Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
    [No Abstract]   [Full Text] [Related]  

  • 93. The rationale for pathogen-inactivation treatment of blood components.
    Barbara JA
    Int J Hematol; 2004 Nov; 80(4):311-6. PubMed ID: 15615254
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation.
    Godbey EA; Thibodeaux SR
    Semin Hematol; 2019 Oct; 56(4):229-235. PubMed ID: 31836028
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Recent decisions on liability for transfusion hepatitis.
    Holder AR
    JAMA; 1974 May; 228(6):786-7. PubMed ID: 4406271
    [No Abstract]   [Full Text] [Related]  

  • 96. Emily Cooley Memorial Award. Managing change to improve transfusion safety.
    AuBuchon JP
    Transfusion; 2004 Sep; 44(9):1377-83. PubMed ID: 15318865
    [No Abstract]   [Full Text] [Related]  

  • 97. Indian Supreme Court demands cleaner blood supply.
    Kumar S
    Lancet; 1996 Jan; 347(8994):114. PubMed ID: 8538304
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Screening--sensitivity, specificity and hepatitis C.
    Davis R
    Med J Aust; 1996 Feb; 164(3):187-8. PubMed ID: 8628143
    [No Abstract]   [Full Text] [Related]  

  • 99. Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.
    O'Brien SF; Zou S; Laperche S; Brant LJ; Seed CR; Kleinman SH
    Transfus Med Rev; 2012 Jan; 26(1):38-57. PubMed ID: 21944935
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Emerging pathogens in transfusion medicine.
    Dodd RY
    Clin Lab Med; 2010 Jun; 30(2):499-509. PubMed ID: 20513567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.